A Explorative Pilot Study to Gain Insights for a New Senior Milk Powder

• • Age 50-70 years (bounds included)

    • Body Mass Index (BMI) between 18.5 (bound included) and 30 (bound excluded) kg/m2.
    • Ability to comply with the protocol and assessment window:
• Product intake according to instructions.

• Willing to collect, store, deliver stool sample according to instructions.

  • Willing to adhere to instructions and restrictions during entire study period*:
• No probiotic supplementations or products supplemented with probiotics.
• No dietary fiber supplements.

• No medications may modify gastrointestinal function.

  • Fluency in speaking, reading and writing in mandarin.
  • Capability of the subject to install and use the secure study platform on the smartphone during entire study period.
  • Written informed consent. *Overruled in case of medical needs.

Exclusion Criteria:

• • Known / Existing gastrointestinal diseases or disorders diagnosed by a physician that may interfere with study.

    • Known / Existing milk protein allergies, lactose intolerance or other allergies to product ingredients.
    • Known / Existing immune diseases or disorders diagnosed by a physician that may interfere with study.
    • Use of any medication may modify gastrointestinal function: tricyclic antidepressants, SSRIs/antidepressants, opioids, ACE inhibitor, bate sympathomimetics, systemic antibiotics, intestinal antiseptics, anti-inflammatory medicines (including nonsteroidal anti-inflammatory drugs [NSAIDs] and aspirin), anti-histamines, steroids, corticosteroids, laxatives, anti-diarrhoea medication, prokinetics/dopamine-antagonists, metformin, statins, or any other stomach medication (including proton pump inhibitor [PPIs], antiacids, and antihistamine2 blockers) within 8 weeks prior to enrolment.
    • Consumption of probiotic supplementations or products supplemented with probiotics within 4 weeks prior to enrolment.
    • Subject following a special diet, including but not limited to vegan diet, ketogenic diet, low fiber diet, thickening diet etc.
    • Incapability to comply with protocol as per the judgement of the investigator.
    • Participation in any other studies involving investigational or marketed products concomitantly or 2 weeks prior to enrolment.
    • Employees and/or children/family member or relatives of employees of Danone or the participating site.